Methylglyoxal is formed in vivo by spontaneous decomposition of triose
phosphate intermediates in aerobic glycolysis. It may also be formed
during oxidative degradation of both carbohydrates (pentoses and ascor
bate) and lipids (arachidonate). In addition to reaction with arginine
residues to form imidazolone adducts, methylglyoxal reacts with lysin
e residues in protein to form N-epsilon-(carboxyethyl)lysine (CEL) and
the imidazolium crosslink, methylglyoxal-lysine dimer (MOLD). Like th
e glycoxidation products, N-epsilon-(carboxymethyl)lysine (CML) and gl
yoxal-lysine dimer (GOLD) which are formed on reaction of glyoxal with
protein, CEL and MOLD increase in lens proteins and skin collagen wit
h age. CML and CEL also increase in skin collagen in diabetes, while a
ll four compounds increase in plasma proteins in uremia. Overall, CML,
GEL, GOLD and MOLD are quantitatively the major biomarkers of the Mai
llard reaction in tissue proteins. GOLD and MOLD, in particular, are p
resent at 10-50 fold higher concentrations than the fluorescent crossl
ink, pentosidine. Together, these dicarbonyl-derived advanced glycatio
n endproducts (AGEs) represent the major chemical modifications that a
ccumulate in tissue proteins with age and in chronic diseases such as
diabetes and atherosclerosis.